An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer

Clinical trial NCT00748358 · COMPLETED

Trial details

NCT number: NCT00748358
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms Neoplasms, Hormone-Dependent Tumor Markers, Biological Survival Rate Disease-Free Survival

Start date: 2008-03-01
Primary completion: 2011-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.